NEW YORK – Since the COVID-19 pandemic started earlier this year, thousands of clinical trials have launched in an effort to better understand the SARS-CoV-2 virus and in search of drugs to successfully treat the symptoms of infection. While these studies are ongoing, doctors are scrambling to make treatment decisions for severely ill COVID-19 patients based on limited, anecdotal evidence on safety and efficacy.
Amid COVID-19 Therapeutic Uncertainty, Experts Look for Potential Role for PGx in Managing Meds
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.